SMO and osteosarcoma: Cyclopamine, a Smo inhibitor, promoted G1-phase arrest of the cell cycle, inhibited expression of cyclin D1, cyclin E1, SKP2, and pRb, and, as a result, restrained the growth of osteosarcoma in vitro (Hirotsu et al. 2010).